These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35663961)

  • 1. Functions of IFNλs in Anti-Bacterial Immunity at Mucosal Barriers.
    Alphonse N; Dickenson RE; Alrehaili A; Odendall C
    Front Immunol; 2022; 13():857639. PubMed ID: 35663961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lambda interferons in immunity and autoimmunity.
    Vlachiotis S; Andreakos E
    J Autoimmun; 2019 Nov; 104():102319. PubMed ID: 31481283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFNλ: balancing the light and dark side in pulmonary infection.
    Antos D; Alcorn JF
    mBio; 2023 Aug; 14(4):e0285022. PubMed ID: 37278532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III interferons in innate and adaptive immunity in the respiratory tract.
    Piperakis A; Galani IE; Andreakos E
    Curr Opin Immunol; 2024 Apr; 87():102430. PubMed ID: 38824869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control.
    Andreakos E; Zanoni I; Galani IE
    Curr Opin Immunol; 2019 Feb; 56():67-75. PubMed ID: 30399529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon Lambda Genetics and Biology in Regulation of Viral Control.
    Hemann EA; Gale M; Savan R
    Front Immunol; 2017; 8():1707. PubMed ID: 29270173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The unique regulation and functions of type III interferons in antiviral immunity.
    Odendall C; Kagan JC
    Curr Opin Virol; 2015 Jun; 12():47-52. PubMed ID: 25771505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.
    Galani IE; Triantafyllia V; Eleminiadou EE; Koltsida O; Stavropoulos A; Manioudaki M; Thanos D; Doyle SE; Kotenko SV; Thanopoulou K; Andreakos E
    Immunity; 2017 May; 46(5):875-890.e6. PubMed ID: 28514692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III IFNs: Beyond antiviral protection.
    Kotenko SV; Rivera A; Parker D; Durbin JE
    Semin Immunol; 2019 Jun; 43():101303. PubMed ID: 31771761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages and neutrophils express IFNλs in granulomas from
    Talukdar P; Junecko BF; Lane DS; Maiello P; Mattila JT
    Front Immunol; 2022; 13():985405. PubMed ID: 36189279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract.
    Andreakos E; Salagianni M; Galani IE; Koltsida O
    Front Immunol; 2017; 8():1232. PubMed ID: 29033947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles and Effects of Interferon Lambda Signaling in the Context of Bacterial Infections.
    Johnson D; Carbonetti N
    J Interferon Cytokine Res; 2023 Sep; 43(9):363-369. PubMed ID: 37289801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon lambda in inflammation and autoimmune rheumatic diseases.
    Goel RR; Kotenko SV; Kaplan MJ
    Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.
    Pervolaraki K; Stanifer ML; Münchau S; Renn LA; Albrecht D; Kurzhals S; Senís E; Grimm D; Schröder-Braunstein J; Rabin RL; Boulant S
    Front Immunol; 2017; 8():459. PubMed ID: 28484457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III interferon induces apoptosis in human lung cancer cells.
    Li W; Huang X; Liu Z; Wang Y; Zhang H; Tong H; Wu H; Lin S
    Oncol Rep; 2012 Sep; 28(3):1117-25. PubMed ID: 22766785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity.
    Van Winkle JA; Constant DA; Li L; Nice TJ
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32847859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential signaling by type-I and type-III interferons in mucosa.
    Stanifer ML; Boulant S
    Curr Opin Immunol; 2024 Feb; 86():102400. PubMed ID: 38118395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon lambda 4 can directly activate human CD19
    Coto-Llerena M; Lepore M; Spagnuolo J; Di Blasi D; Calabrese D; Suslov A; Bantug G; Duong FH; Terracciano LM; De Libero G; Heim MH
    Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33158978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells-A Strategy Used by Coxsackie B Virus to Evade the Host's Innate Immune Response at the Primary Site of Infection?
    Stone VM; Ringqvist EE; Larsson PG; Domsgen E; Holmlund U; Sverremark-Ekström E; Flodström-Tullberg M
    Microorganisms; 2021 Jan; 9(1):. PubMed ID: 33466313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship.
    Finotti G; Tamassia N; Cassatella MA
    Front Immunol; 2017; 8():1015. PubMed ID: 28878776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.